Neuren Pharmaceuticals Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: 0.397x

Neuren Pharmaceuticals Ltd cash flow conversion efficiency. Based on the latest financial reports, Neuren Pharmaceuticals Ltd (NEU) has a cash flow conversion efficiency ratio of 0.397x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$128.31 Million ≈ $90.78 Million USD) by net assets (AU$323.27 Million ≈ $228.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Neuren Pharmaceuticals Ltd (2002–2024)

Cash flow conversion efficiency of Neuren Pharmaceuticals Ltd from 2002 to 2024. This chart illustrates how Neuren Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NEU live share price for real-time trading data and today's change.

Neuren Pharmaceuticals Ltd Cash Flow Conversion Ratio Explained

Neuren Pharmaceuticals Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Neuren Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neuren Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. Also see NEU market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Ziraat Gayrimenkul Yatirim Ortakligi AS IS:ZRGYO	0.009x
PG Electroplast Limited NSE:PGEL	-0.050x
Changzhou NRB Corp SHE:002708	0.042x
Diversified Healthcare Trust NASDAQ:DHC	0.024x
Marqeta Inc NASDAQ:MQ	88.289x
RLJ Lodging Trust NYSE:RLJ	0.053x
Mirae Asset Life Insurance Co Ltd KO:085620	0.219x
Solvac S.A. BR:SOLV	0.011x

Annual Cash Flow Conversion Efficiency for Neuren Pharmaceuticals Ltd (2002–2024)

The table below shows the annual cash flow conversion efficiency of Neuren Pharmaceuticals Ltd from 2002 to 2024. Review Neuren Pharmaceuticals Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$363.90 Million ≈ $257.49 Million	AU$-11.27 Million ≈ $-7.97 Million	-0.031x	-103.44%
2023-12-31	AU$205.21 Million ≈ $145.20 Million	AU$184.93 Million ≈ $130.85 Million	0.901x	+941.36%
2022-12-31	AU$41.59 Million ≈ $29.43 Million	AU$3.60 Million ≈ $2.55 Million	0.087x	+134.07%
2021-12-31	AU$39.25 Million ≈ $27.77 Million	AU$-9.97 Million ≈ $-7.05 Million	-0.254x	+23.91%
2020-12-31	AU$24.20 Million ≈ $17.12 Million	AU$-8.08 Million ≈ $-5.72 Million	-0.334x	+60.56%
2019-12-31	AU$13.85 Million ≈ $9.80 Million	AU$-11.72 Million ≈ $-8.29 Million	-0.846x	-425.81%
2018-12-31	AU$24.67 Million ≈ $17.45 Million	AU$6.41 Million ≈ $4.53 Million	0.260x	+176.04%
2017-12-31	AU$16.36 Million ≈ $11.58 Million	AU$-5.59 Million ≈ $-3.96 Million	-0.342x	+88.46%
2016-12-31	AU$4.18 Million ≈ $2.96 Million	AU$-12.38 Million ≈ $-8.76 Million	-2.959x	-234.75%
2015-12-31	AU$14.40 Million ≈ $10.19 Million	AU$-12.73 Million ≈ $-9.01 Million	-0.884x	-163.10%
2014-12-31	AU$19.08 Million ≈ $13.50 Million	AU$-6.41 Million ≈ $-4.54 Million	-0.336x	-6.14%
2013-12-31	AU$24.36 Million ≈ $17.23 Million	AU$-7.71 Million ≈ $-5.45 Million	-0.317x	+31.96%
2012-12-31	AU$6.34 Million ≈ $4.49 Million	AU$-2.95 Million ≈ $-2.09 Million	-0.465x	-40.59%
2011-12-31	AU$9.45 Million ≈ $6.69 Million	AU$-3.13 Million ≈ $-2.21 Million	-0.331x	+59.31%
2010-12-31	AU$3.53 Million ≈ $2.50 Million	AU$-2.87 Million ≈ $-2.03 Million	-0.813x	-364.34%
2009-12-31	AU$7.35 Million ≈ $5.20 Million	AU$-1.29 Million ≈ $-910.66K	-0.175x	+89.20%
2008-12-31	AU$5.57 Million ≈ $3.94 Million	AU$-9.04 Million ≈ $-6.40 Million	-1.622x	-6.50%
2007-12-31	AU$7.55 Million ≈ $5.34 Million	AU$-11.50 Million ≈ $-8.14 Million	-1.523x	-169.10%
2006-12-31	AU$16.15 Million ≈ $11.42 Million	AU$-9.14 Million ≈ $-6.47 Million	-0.566x	-116.92%
2005-12-31	AU$32.16 Million ≈ $22.75 Million	AU$-8.39 Million ≈ $-5.94 Million	-0.261x	+37.81%
2004-12-31	AU$8.77 Million ≈ $6.20 Million	AU$-3.68 Million ≈ $-2.60 Million	-0.420x	-232.00%
2003-12-31	AU$-14.72 Million ≈ $-10.41 Million	AU$-4.68 Million ≈ $-3.31 Million	0.318x	+111.17%
2002-12-31	AU$1.82 Million ≈ $1.29 Million	AU$-5.19 Million ≈ $-3.67 Million	-2.846x	--

About Neuren Pharmaceuticals Ltd

AU:NEU Australia Biotechnology

Market Cap

$2.08 Billion

AU$2.94 Billion AUD

Market Cap Rank

#6515 Global

#160 in Australia

Share Price

AU$23.24

Change (1 day)

+17.49%

52-Week Range

AU$11.28 - AU$23.64

All Time High

AU$25.11